# Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer

> **NCT01996969** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 117 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Regorafenib

## Key facts

- **NCT ID:** NCT01996969
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-06
- **Final completion:** 2016-05
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2019-02-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01996969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01996969, "Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01996969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*